
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [SRPT] Sarepta Therapeutics Inc
Data updated 2025-May-23 (Friday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab

Share
2025-May-23 Friday
Open | $38.00 | High | $38.41 +1.08% |
---|---|---|---|
Close | $37.90 | Low | $37.64 -0.95% |
Volume | 2.05 Million 0.91x | Volatility | 2.05% |
Change |
$-0.89
-2.29%
|
Streak | ↓ 2 days -5.37% |
20d SMA | $45.28 -16.3% | 50d SMA | $56.86 -33.4% | 100d SMA | $84.74 -55.3% | 200d SMA | $105.39 -64.0% |
RSI | 31 | MACD | 0.62 | ADX | 39.3 | Stochastic Oscillator | 15.8 16.9 |
CCI | -48.4 | ATR | 3.4 | OBV | 234 Million | Chaikin A/D | -54.6 Million |
Market Cap | 11.8 B | PEG Ratio | Trailing P/E | Forward P/E | 36.1 | ||
Price/Sales (ttm) | 9.36 | Price/Book (mrq) | 13.8 | EV/Revenue (ttm) | 9.29 | EV/EBITDA (ttm) | -25.5 |
% Held by Insiders | 4.30% | % Held by Institutions | 87.99% | Shares Short | 4.97 M | Shares Short (prior month) | 4.81 M |
Short Ratio | 4.69 | Short % of Outstanding | 5.30% | Short % of Float | 5.55% | Shares Short Change (mom) | +3.3% |
Revenue/Share (ttm) | $13.46 | Profit Margin (ttm) | -43.11% | Operating Margin (ttm) | 6.21% | EBITDA (ttm) | -223 M |
Diluted EPS (ttm) | $-5.79 | Current Ratio (mrq) | 3.95 | Return on Assets (ttm) | -5.24% | Return on Equity (ttm) | -86.15% |
Qtr Earnings Growth (yoy) | Qtr Revenue Growth (yoy) | 53.50% | Operating Cash Flow (ttm) | -501 M | Free Cash Flow (ttm) | -348 M | |
Choose view type
Daily Performance for Sarepta Therapeutics Inc. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Sarepta Therapeutics Inc up to close of 2025-May-23 at $37.90
3-month Performance Benchmarks for Sarepta Therapeutics Inc:
Related to Sarepta Therapeutics Inc
Information for Sarepta Therapeutics Inc
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-23 on Google
SEC Reports : Quarterly reports around 2025-May-23 on SEC Edgar
Compare Sarepta Therapeutics Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Sarepta Therapeutics Inc
Industry : Biotechnology industry performance which includes Sarepta Therapeutics Inc